Despite exciting progress in the field of neuroprotection, lowering the intraocular pressure
(IOP) is still the only available option to treat glaucoma patients. Several studies have shown …

Glaucoma is a progressive optic neuropathy that is a leading cause of irreversible blindness
worldwide. 1 Elevated intraocular pressure (IOP) is commonly associated with glaucoma …

Given that glaucoma is a disease of the central nervous system, there must be greater
emphasis and focus on developing intraocular pressure–independent therapies. In addition …

Primary open‐angle glaucoma (POAG) is a leading cause of irreversible and preventable
blindness and ocular hypertension is the strongest known risk factor. With current classes of …

For some time the medical treatment of glaucoma has consisted of topical β-blockers,
adrenergic agents, miotics and oral carbonic anhydrase inhibitors (CAIs). However, the …

Prescribing medical therapy for the treatment of glaucoma can be a complex process since
many parameters should be taken into consideration regarding its achievements and limits …

Primary open angle glaucoma (POAG) is the most common type of glaucoma, and is
responsible for approximately 90% of glaucoma cases in North America. POAG is …

Glaucoma is a complex, life-long disease that requires an individualized, multifaceted
approach to treatment. Most patients will be started on topical ocular hypotensive eyedrop …

Purpose: Two features define the future of glaucoma therapeutics:(1) greatly improved
ocular hypotensive efficacy and (2) a delivery method that improves patient convenience …

Aim: To systematically review the literature on the efficacy and harm of prostaglandin
analogues (PGAs) compared to brimonidine and dorzolamide in treating elevated …